Literature DB >> 26266165

Spontaneous Resolution of Non Traumatic Chronic Subdural Haematoma Despite Continued Antiplatelet Therapy: A Case Report.

Ajeet Ramamani Tiwari1, Shradha Maheshwari2, Srikant Balasubramaniam2, Tyagi Devendra3, Hemantkumar Savant4.   

Abstract

Spontaneous resolution of traumatic chronic subdural haematoma (CSDH) has been reported in literature. However, those with non traumatic CSDH are exceedingly rare and none reported with continued antiplatelet therapy where it itself is an aetiological agent for development of non traumatic CSDH. A 50-year-old male presented to us with a non haemorrhagic cerebellar infarct with a concomitant CSDH without history of any trauma. Patient's PT/INR, Bleeding time and Clotting time were normal. Patient was started on antiplatelet therapy (Tablet Aspirin 150 mg OD) for the acute infarct. MR Brain at 1 month showed an increased size of CSDH. However patient denied surgical evacuation hence we continued conservative line of management, however we continued anti-platelet therapy with close neurological and coagulation profile monitoring that remained within normal range throughout the period of observation. CT at 5(th) month showed complete resolution of CSDH. Patient was on antiplatelet drugs throughout the period of observation. Our case argues about the role of antiplatelet therapy in patients with CSDH with contrary lesions requiring anticoagulation.

Entities:  

Keywords:  Anticoagulation; Haemorrhagic; Ischemic heart disease

Year:  2015        PMID: 26266165      PMCID: PMC4525554          DOI: 10.7860/JCDR/2015/11864.6002

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

1.  Chronic subdural hematoma in adults. Influence of patient's age on symptoms, signs, and thickness of hematoma.

Authors:  R Fogelholm; O Heiskanen; O Waltimo
Journal:  J Neurosurg       Date:  1975-01       Impact factor: 5.115

2.  Spontaneous resolution of chronic subdural hematoma.

Authors:  C Parlato; A Guarracino; A Moraci
Journal:  Surg Neurol       Date:  2000-04

3.  Spontaneous resolution of chronic subdural hematomas.

Authors:  H Naganuma; A Fukamachi; M Kawakami; S Misumi; H Nakajima; T Wakao
Journal:  Neurosurgery       Date:  1986-11       Impact factor: 4.654

4.  The role of endothelial gap junctions in the enlargement of chronic subdural hematomas.

Authors:  T Yamashima; S Yamamoto; R L Friede
Journal:  J Neurosurg       Date:  1983-08       Impact factor: 5.115

5.  Effect of addition of clopidogrel to aspirin on subdural hematoma: meta-analysis of randomized clinical trials.

Authors:  Majid F Bakheet; Lesly A Pearce; Robert G Hart
Journal:  Int J Stroke       Date:  2014-12-03       Impact factor: 5.266

6.  Computed tomography characteristics suggestive of spontaneous resolution of chronic subdural hematoma.

Authors:  T Horikoshi; H Naganuma; I Fukasawa; M Uchida; H Nukui
Journal:  Neurol Med Chir (Tokyo)       Date:  1998-09       Impact factor: 1.742

7.  Chronic subdural hematoma in elderly people: present status on Awaji Island and epidemiological prospect.

Authors:  H Kudo; K Kuwamura; I Izawa; H Sawa; N Tamaki
Journal:  Neurol Med Chir (Tokyo)       Date:  1992-04       Impact factor: 1.742

Review 8.  Spontaneous resolution of a large chronic subdural hematoma: a case report and review of the literature.

Authors:  Ethem Göksu; Mahmut Akyüz; Tanju Uçar; Saim Kazan
Journal:  Ulus Travma Acil Cerrahi Derg       Date:  2009-01

9.  Complete spontaneous resolution of compressive chronic subdural hematoma in a patient with liver failure.

Authors:  Mirela Juković; Zeljko Kojadinović; Biljana Popovska; Viktor Till
Journal:  Med Glas (Zenica)       Date:  2012-08

10.  Spontaneous resolution of nontraumatic chronic subdural hematoma associated with anti-aggregation therapy.

Authors:  Shaofeng Yang; Xiaohua Zhang; Yichao Jin
Journal:  J Craniofac Surg       Date:  2014-07       Impact factor: 1.046

  10 in total
  1 in total

1.  Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized ClinicalTrial.

Authors:  Rongcai Jiang; Shiguang Zhao; Renzhi Wang; Hua Feng; Jianmin Zhang; Xingang Li; Ying Mao; Xianrui Yuan; Zhou Fei; Yuanli Zhao; Xinguang Yu; Wai Sang Poon; Xide Zhu; Ning Liu; Dezhi Kang; Tao Sun; Baohua Jiao; Xianzhi Liu; Rutong Yu; Junyi Zhang; Guodong Gao; Jiehe Hao; Ning Su; Gangfeng Yin; Xingen Zhu; Yicheng Lu; Junji Wei; Jin Hu; Rong Hu; Jianrong Li; Dong Wang; Huijie Wei; Ye Tian; Ping Lei; Jing-Fei Dong; Jianning Zhang
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.